Shopping Cart
- Remove All
- Your shopping cart is currently empty
Foravirumab (CR4098) is a monoclonal antibody targeting rabies virus glycoprotein (RABV-G) for the study of infectious diseases such as rabies.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $228 | In Stock | |
5 mg | $589 | In Stock | |
10 mg | $959 | In Stock | |
25 mg | $1,420 | In Stock | |
50 mg | $1,920 | In Stock |
Description | Foravirumab (CR4098) is a monoclonal antibody targeting rabies virus glycoprotein (RABV-G) for the study of infectious diseases such as rabies. |
In vitro | Foravirumab (CR4098) recognizes a specific epitope located at antigenic site III. Foravirumab binds even to the mutant glycoprotein (N336D) expressed on PER.C6 cells. Foravirumab has a neutralizing potency and broad spectrum similar to CR57 and also neutralizes escape mutants of CR57. [1] |
In vivo | Foravirumab (10, 20, and 40 IU/kg) was effective in preventing fatal rabies virus infection in Syrian hamsters infected with natural rabies virus. [1] |
Alias | CR4098, CR 4098, CL-184, CL184 |
Cas No. | 944548-38-3 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.